Nasal vs. Injectable: A Research Guide

Ask about exposure, not convenience

A route comparison should ask where the material is expected to go, how exposure is measured, and what endpoint is being evaluated. Convenience is not evidence of equivalent exposure. Dose labels alone cannot demonstrate equivalence.

Formulation includes solvent, concentration, excipients, container, and delivery device. A different device or chemical variant can change the relevance of a study even when the familiar compound name stays the same.

Oxytocin: a worked comparison

A 2020 human study compared standard nasal spray, a nasal nebulizer, and intravenous oxytocin using regional cerebral blood-flow measurements. Some findings related to systemic exposure, while others supported route-specific brain effects. It illustrates why route claims need direct testing. [1]

The result concerns oxytocin under that study design. It does not prove that every peptide spray reaches the same targets or that a commercial spray duplicates the study device. The paper also has a published correction, which should be read with the original.

A product is not a research protocol

The Real Peptides catalog includes prepared Semax and Selank liquid sprays and separate peptide variants. Match the exact identity and format to your research method. An amidated analog should not be treated as interchangeable with the parent peptide without supporting evidence.

Injectable in a product label does not mean the material is approved for clinical administration. This guide describes research design; it does not provide instructions for personal nasal use or injection.

Your comparison worksheet

Create one row per route with fields for the research question, compound identity, vehicle, device, model, exposure measurement, endpoint, and limitation. If exposure was not measured, mark it unknown rather than assuming equivalence.

When sourcing research materials, evaluate the format that fits the approved experiment. Review current certificates and handling instructions first. Choose materials for a defined method instead of selecting a route based on a general benefit claim.

Match the material to the method.

Review identity, format, current availability, and batch documentation before laboratory procurement. These links identify relevant catalog materials; they do not validate a personal-use protocol.

Sources & further reading

1. Oxytocin route comparison and cerebral blood flow, 2020

   PubMed abstract or indexed study summary reviewed; full-text verification required before expanding claims.

2. Published correction to the route-comparison paper, 2022

   Correction identified in the PubMed record; consult alongside original.

Study summaries are educational. A published clinical study does not authorize administration of Real Peptides laboratory materials.